| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 07/12/2007 | WO2007011903A3 Analyzing messenger rna and micro rna in the same reaction mixture |
| 07/12/2007 | US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 07/11/2007 | EP1804820A2 Vasoactive intestinal polypeptide pharmaceuticals |
| 07/11/2007 | EP1781706A4 New chiral columns with broad chiral selectivity |
| 07/11/2007 | CN1997671A Peptide purification by means of hard metal ion affinity chromatography |
| 07/11/2007 | CN1325645C Histamine and serotonin binding molecules |
| 07/11/2007 | CN1325518C Cell membrane antigen preservation method and magnetic particle envelope human cell membrane antigen |
| 07/11/2007 | CN1325513C Oil bodies and associated proteins as affinity matrices |
| 07/10/2007 | US7241883 Functionalized compositions for improved immobilization |
| 07/10/2007 | US7241744 Delivering into cells of the subject an effective amount of a nucleic acid expression construct that encodes a growth-hormone-releasing-hormone ("GHRH") or functional biological equivalent thereof for therapy of anemia |
| 07/10/2007 | US7241576 Applications of a novel cytokine, named THANK, for TNF homologue that activates apoptosis, NF- kappa B and c-jun N-terminal kinase. Such applications include using THANK inhibitors to inhibit the activation of NF-kappa B and to |
| 07/10/2007 | US7241449 Recombinant Tbp2 protein of Moraxella catarrhalis strain M35, 3 or LES1, used in diagnostics and in vaccines |
| 07/10/2007 | CA2203129C Creating an aerosolized formulation of insulin |
| 07/05/2007 | WO2007044321A3 Latent procytotoxins and uses thereof |
| 07/05/2007 | US20070154552 Biologically active native biomatrix composition |
| 07/04/2007 | EP1121382B9 Interferon-beta fusion proteins and uses |
| 07/04/2007 | CN1990037A Thymosin alpha1 active fragment and polyethylene glycol derivative thereof |
| 07/03/2007 | US7238787 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/03/2007 | US7238779 Comprises acyl CoA:cholesterol acyltransferase polypeptide for use in treatment and prevention of gall stones; enzyme inhibitors |
| 07/03/2007 | US7238344 Interferon-β variants and conjugates |
| 07/03/2007 | CA2274956C Method of coupling ligands to a solid phase in acidic solution and anionic surfactant |
| 06/28/2007 | WO2007072982A1 Protein nanoparticles and the use of the same |
| 06/28/2007 | WO2007050569A3 Polypeptide multilayer films and methods |
| 06/28/2007 | WO2006132701A3 Methods and kits for regulation of microtubule assembly and dendrite growth and branching |
| 06/28/2007 | US20070149761 To evaluate the effectiveness of a compound to inhibit NS5B activity |
| 06/28/2007 | US20070149446 Tamandarin analogs and fragments thereof and methods of making and using |
| 06/28/2007 | CA2633801A1 Cyclodextrin-containing polymers and uses thereof |
| 06/27/2007 | EP0851870B1 Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 06/27/2007 | CN1323294C Method for preparing water-soluble cross-linked conjugates |
| 06/26/2007 | US7235632 for diagnosing malignant and benign hemopathies; isolated human cell surface protein wherein said protein; expressed at the surface of human lymphoid progenitor cells and mature NK cells |
| 06/26/2007 | US7235242 use as a carrier for a conjugate, particularly in combination with a polysaccharide, and a process for producing the peptide as well as vaccines comprising said peptide |
| 06/21/2007 | WO2007068047A1 Multimeric fc receptor polypeptides |
| 06/21/2007 | WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 06/21/2007 | US20070141087 Compounds and methods for diagnosis of tuberculosis |
| 06/20/2007 | CN1982348A Porous integrated substrate of solid carried protein and its production |
| 06/19/2007 | US7232686 Method of nanopatterning by forming cracks in a coated polymer substrate |
| 06/19/2007 | US7232562 E38N interferon gamma polypeptide variants |
| 06/14/2007 | WO2007014253A3 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 06/14/2007 | US20070134653 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases |
| 06/14/2007 | CA2826960A1 Targeting vector-phospholipid conjugates |
| 06/13/2007 | EP1746902A4 Multi-lectin affinity chromatography and uses thereof |
| 06/13/2007 | EP1583816A4 Protein arrays |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/12/2007 | US7230081 Interferon gamma conjugates |
| 06/12/2007 | US7229782 Immunogens used to produce the antibodies |
| 06/12/2007 | CA2214649C Antigen presenting system and methods for activation of t-cells |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/06/2007 | EP1791969A2 A method of treating cancer |
| 06/05/2007 | US7227000 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 06/05/2007 | US7226992 proteins of the present invention can be used in biological assays to identify substances which block the ability of Bcl-2 to inhibit programmed cell death |
| 06/05/2007 | US7226602 Recombinant flavivirus for use in generation of vaccines to prevent and treat hemorrhagic fever |
| 06/05/2007 | US7226591 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
| 05/31/2007 | WO2007000343A3 Process for manufacturing vaccines |
| 05/31/2007 | WO2006010155A8 Gonadotropin releasing hormone antagonists |
| 05/31/2007 | US20070123696 G-csf conjugates |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/30/2007 | EP1601697B1 Antibody purification by Protein A and ion exchange chromatography |
| 05/30/2007 | EP0885393B1 Graphitic nanotubes in luminescence assays |
| 05/30/2007 | CN1970572A Interferon alpha mutant and its polyethylene glycol derivative |
| 05/30/2007 | CN1970571A G-csf analog compositions and methods |
| 05/30/2007 | CN1970086A Monomodified PEGylated insulin and its preparation method |
| 05/30/2007 | CN1318023C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/29/2007 | US7223846 Urocortin proteins and uses thereof |
| 05/29/2007 | US7223553 Immunoassays for everolimus |
| 05/29/2007 | US7223547 for drug screening using genomic expression libraries; solid phase synthesis; kits; genetic engineering |
| 05/24/2007 | WO2007059242A1 Low-density lipoprotein receptor-related protein 2 clears amyloid-beta peptide a cross the blood-brian barrier via apolipoprotein j |
| 05/24/2007 | US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 05/23/2007 | EP1786450A2 Hiv immunostimulatory compositions |
| 05/23/2007 | EP1786273A2 Sequential protein isolation and purirication schemes by affinity chromatography |
| 05/23/2007 | CN1966528A PEG-W conjugate linked by urea alkyl bond and its preparation method |
| 05/23/2007 | CN1966527A Polyethylene glycol-interferon coupler and its preparation method |
| 05/22/2007 | US7220842 Immunoassays for buprenorphine and norbuprenorphine |
| 05/22/2007 | US7220725 Pharmaceutical composition comprising an analgesic peptide and method for treating pain |
| 05/22/2007 | US7220420 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 05/22/2007 | CA2143187C Anti-feline immunodeficiency virus (fiv) vaccines |
| 05/22/2007 | CA2111645C Fibrinogen fragment e peptides and antibodies thereto |
| 05/18/2007 | WO2007055178A1 Method of cell fractionation and substrate to be used for the method |
| 05/18/2007 | WO2007054030A1 Polyethylene glycol modifications of thymosin alpha-1 |
| 05/18/2007 | WO2006042152A3 Vasoactive intestinal polypeptide pharmaceuticals |
| 05/18/2007 | CA2624393A1 Use of complement pathway inhibitors to treat ocular diseases |
| 05/17/2007 | US20070110750 Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 05/16/2007 | EP1415006B1 Assay for identifying inhibitors of hiv rt dimerization |
| 05/16/2007 | EP1355928B1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 05/16/2007 | CN1962693A Long-acting thymosin alpha1 polyethylene glycol modifier |
| 05/15/2007 | US7217806 Gene defective in APECED and its use |
| 05/15/2007 | US7217802 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine |
| 05/10/2007 | WO2007051605A2 Methods for determining the cleavability of substrates |
| 05/10/2007 | WO2004060910A3 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 05/10/2007 | WO2003076567A3 Heterologous g-csf fusion proteins |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105145 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions. |
| 05/10/2007 | US20070105131 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/10/2007 | DE102005051978A1 Verfahren zur Bestimmung der Spaltbarkeit von Substraten Method for determining the cleavage of substrates |
| 05/09/2007 | EP1781706A1 New chiral columns with broad chiral selectivity |
| 05/09/2007 | CN1314708C Human alpha 1-thymic peptide composition and its preparation |
| 05/08/2007 | US7214765 Applying a gyroscopic force to a low concentration slurry of polymer fibers, evenly dispersed and randomly oriented throughout the volume of the suspension fluid, to cause the fibers to flocculate and migrate through the fluid and amass at a center point where they interlace with one another |
| 05/08/2007 | US7214657 Method of transporting a chimeric hybrid molecule across the blood brain barrier |
| 05/08/2007 | US7214656 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents |
| 05/08/2007 | US7214388 Gels; immobilization of proteins; drug delivery |
| 05/03/2007 | WO2006113958A3 Affinity ligands |